1-1 of 1 results for subject:Pfizer
Librarians' tools
- Search time
- 0.211 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Primary member
X
Whittome, Nadia
Type
House
Session
Year
Department
Member
Primary member
More
Whittome, Nadia (1)
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, what assessment he has made of the efficacy of the (a) Pfizer and (b) Moderna vaccine after 12 weeks; and if he will publish those assessments.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the efficacy of the (a) Pfizer and (b) Moderna vaccine after 12 weeks; and if he will publish those assessments.
Asked by
Nadia Whittome
(Labour)
Answered by
Nadhim Zahawi
(Conservative)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Tabled on
12 April 2021
For answer on
14 April 2021
Answered on
19 April 2021
There is no data on the efficacy of the Moderna or Pfizer/BioNTech vaccine 12 weeks after the first dose. Given the high effectiveness and durability of responses to the first dose seen in United Kingdom data, it is not expected that protection will reduce rapidly after 12 weeks.
Subjects
Standards; Vaccination; Pfizer; Coronavirus; Moderna
Date
19 April 2021
Reference
179721
House
House of Commons